Company Directory / health
PrivateFor profithealthSan Francisco, United States
Darmiyan
Darmiyan is developing an AI-powered software platform for early detection, monitoring, and stratification of Alzheimer's disease
- Founded
- 2016 10 years ago
- Staff
- 1-10 band, as listed
- Followers
- - on LinkedIn
- Funding
- $15M as listed, currency not stated
Set against six million companies
Size
1-10 people: larger than 0% of companies with a size listed
Age
10 years old.
Reach
Website ranked #10,244,341 in the world for traffic, about 243 visits a month.
What it does
Artificial Intelligence (AI)BiotechnologyEnterprise SoftwareHealth CareHealth DiagnosticsMachine LearningMedicalSoftware
Funding, as listed
$15M currency not stated
- Rounds6
- LatestSeries unknown, Oct 2023
- Investors18, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Darmiyan, field by field. Contact details are held but never shown.
The company
- Name
- Darmiyan
- Type
- For profit
- Status
- Private
- Founded
- 2016
- Founders
- Kaveh Vejdani, Padideh Kamali-Zare, Thomas Liebmann
- Industry
- health
- Categories
- Artificial Intelligence (AI), Biotechnology, Enterprise Software, Health Care, Health Diagnostics, Machine Learning, Medical, Software
Where
- City
- San Francisco
- Country
- United States
- Markets
- San Francisco Bay Area, West Coast, Western US
Size and reach
- Staff band
- 1-10
- Web traffic rank
- #10,244,341
- Monthly web visits
- 243
Funding, as listed
- Total
- 14,588,499 (currency not stated)
- Rounds
- 6
- Latest round
- Series unknown
- Latest round date
- Oct 2023
- Investors
- 18
- Lead investors
- 1
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Darmiyan may be growing as it has recently received FDA approval for BrainSee, which is the first prognostic test for predicting the likelihood of progression to Alzheimer's dementia. This regulatory milestone is a significant achievement for a company in the biotechnology and health diagnostics industry, as it can lead to increased adoption and integration of their AI-powered software platform in clinical settings. The FDA approval is indicative of the company's ability to meet stringent regulatory standards, which may enhance its reputation and credibility in the medical and health care sectors.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
health in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.